PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayIn a multicenter prospective cohort study tracking adult patients receiving maintenance hemodialysis, higher baseline phase angle was associated with lower all-cause mortality in initial evaluations, but the relationship was attenuated and lost statistical significance once researchers adjusted for diabetes mellitus. The findings, reported in the Journal of Health, Population and Nutrition, also revealed that serum transthyretin was not significantly associated with mortality across any statistical model. Furthermore, formal interaction testing demonstrated no evidence that transthyretin levels modified the association between phase angle and patient survival.
Malnutrition represents a major determinant of mortality among patients undergoing maintenance hemodialysis, yet its multidimensional nature is not fully captured by individual biomarkers alone. To evaluate complementary domains of patient assessment, investigators evaluated phase angle alongside serum transthyretin. Phase angle serves as a marker related to cellular integrity and body composition, whereas serum transthyretin functions as an inflammation-sensitive biochemical marker reflecting visceral protein status. The primary objectives of the study were to investigate the separate associations of both markers with all-cause mortality and to determine whether the relationship between phase angle and mortality differed across varying levels of serum transthyretin.
The multicenter prospective cohort enrolled 307 adults receiving maintenance hemodialysis and followed them over a median observation period of 36.9 months, with an interquartile range extending from 27.5 to 39.3 months. Baseline phase angle and serum transthyretin were assessed concurrently at study entry. Over the course of the complete follow-up period, 98 of the 307 participants died, representing an overall all-cause mortality rate of 31.9 percent within the evaluated patient population.
To evaluate survival associations, the research team constructed multivariable Cox proportional-hazards regression models. The initial unadjusted crude model evaluated phase angle directly, while Model 1 adjusted for key baseline demographic and clinical covariates, including participant age, sex, Kt/V, dialysis session duration, dialysis frequency, dialysis vintage, and the underlying cause of kidney failure. A subsequent multivariable specification, Model 2, incorporated diabetes mellitus alongside all covariates from Model 1 to determine whether metabolic comorbidity influenced the observed mortality estimates.
In the crude Cox proportional-hazards analysis, higher baseline phase angle was significantly associated with a reduced hazard of all-cause mortality, yielding a hazard ratio of 0.850 with a 95 percent confidence interval of 0.776 to 0.931 and a P value of less than 0.001. This inverse association persisted in Model 1 after controlling for age, sex, Kt/V, dialysis session duration, dialysis frequency, dialysis vintage, and cause of kidney failure, demonstrating a hazard ratio of 0.853, a 95 percent confidence interval of 0.771 to 0.944, and a P value of 0.002. However, upon additional adjustment for diabetes mellitus in Model 2, the association between phase angle and mortality was attenuated, producing a hazard ratio of 0.879, a 95 percent confidence interval of 0.758 to 1.018, and a non-significant P value of 0.085.
Serum transthyretin exhibited no statistically significant association with all-cause mortality in the crude model or in either of the multivariable adjusted models. To formally examine potential effect modification between the two nutritional measures, transthyretin was modeled continuously in statistical interaction tests, which confirmed no significant evidence of a phase angle by transthyretin interaction. In exploratory stratified analyses using the cohort median transthyretin concentration of 40.38 milligrams per deciliter, the inverse association between phase angle and mortality remained statistically significant in the lower-transthyretin subgroup before adjustment for diabetes, whereas the higher-transthyretin subgroup demonstrated a borderline association in crude analysis with a hazard ratio of 0.782 and a 95 percent confidence interval of 0.611 to 1.001.
Discriminatory performance for all-cause mortality was subsequently evaluated at the 36-month mark using time-dependent receiver operating characteristic curve analysis. Both phase angle and serum transthyretin demonstrated modest discriminatory performance for predicting mortality at this time point. Ultimately, the authors concluded that although higher phase angle correlated with decreased all-cause mortality, the relationship weakened after accounting for diabetes mellitus, and the data provided no evidence of effect modification across transthyretin concentrations, failing to support a differential phase angle and mortality association across transthyretin levels.
Subject of Research: Phase angle, serum transthyretin, and all-cause mortality in maintenance hemodialysis patients
Article Title: Phase angle and transthyretin in relation to all-cause mortality in hemodialysis patients: a multicenter prospective cohort study
Article References: Navab, F., Heidari, Z., Moeinzadeh, F., & Rouhani, M. H. (2026). Phase angle and transthyretin in relation to all-cause mortality in hemodialysis patients: a multicenter prospective cohort study. Journal of Health, Population and Nutrition. https://doi.org/10.1186/s41043-026-01490-9
Image Credits: AI Generated
DOI: 10.1186/s41043-026-01490-9
Keywords: phase angle, serum transthyretin, hemodialysis, all-cause mortality, multicenter prospective cohort, malnutrition, cellular integrity, body composition, visceral protein status, Cox proportional-hazards models, Kt/V, dialysis vintage, diabetes mellitus, time-dependent ROC analysis, interaction testing, kidney failure


1 hour ago
7




















English (US) ·
French (CA) ·